The use of procalcitonin in patients with surgical forms of erysipelas

The ideal marker of bacterial infection should not only allow for early diagnosis, but also provide information about the course and prognosis of the disease. Nowadays the most well-studied and widely used in clinical practice is procalcitonin (PCT), but its value in surgical forms of erysipelas is...

Full description

Saved in:
Bibliographic Details
Main Authors: S.D. Shapoval, L.A. Vasylevska
Format: Article
Language:English
Published: Dnipro State Medical University 2021-03-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/228011
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846146924389859328
author S.D. Shapoval
L.A. Vasylevska
author_facet S.D. Shapoval
L.A. Vasylevska
author_sort S.D. Shapoval
collection DOAJ
description The ideal marker of bacterial infection should not only allow for early diagnosis, but also provide information about the course and prognosis of the disease. Nowadays the most well-studied and widely used in clinical practice is procalcitonin (PCT), but its value in surgical forms of erysipelas is insufficiently defined. The aim of the article is to determine the diagnostic and prognostic significance of procalcitonin in patients with surgical forms of erysipelas.114 case histories of patients who were hospitalized in the center of purulent-septic surgery of the Non-profit municipal enterprise "City Hospital №3" in Zaporozhye for 2019-2020 period were analyzed retrospectively and prospectively. It was found that most often the focus was localized on the lower extremities. In the complex treatment of patients with erysipelas, the main place belongs to antibiotic therapy (ABT) and early surgical treatment of the area of the pathological process. Determination of the level of procalcitonin in the serum makes it possible to assess the progression and generalization of the process and is a sensitive test for the effectiveness of treatment.Radical surgery and timely targeted ABT are key elements of success in the treatment of surgical forms of erysipelas and are not subject to revision. Procalcitonin is a diagnostic marker that can predict the development of sepsis.
format Article
id doaj-art-df2011a361a74ef7bed3bf4261c84d82
institution Kabale University
issn 2307-0404
language English
publishDate 2021-03-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-df2011a361a74ef7bed3bf4261c84d822024-12-02T00:47:56ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042021-03-0126119620010.26641/2307-0404.2021.1.228011265554The use of procalcitonin in patients with surgical forms of erysipelasS.D. Shapoval0https://orcid.org/0000-0001-8516-9494L.A. Vasylevska1https://orcid.org/0000-0002-0607-5279SI «Zaporizhzha Medical Academy of post-graduate education Ministry of Health of Ukraine», Institute of Sepsis, Wintera blvd., 20, Zaporizhzhia, 69096, UkraineSI «Zaporizhzha Medical Academy of post-graduate education Ministry of Health of Ukraine», Institute of Sepsis, Wintera blvd., 20, Zaporizhzhia, 69096, UkraineThe ideal marker of bacterial infection should not only allow for early diagnosis, but also provide information about the course and prognosis of the disease. Nowadays the most well-studied and widely used in clinical practice is procalcitonin (PCT), but its value in surgical forms of erysipelas is insufficiently defined. The aim of the article is to determine the diagnostic and prognostic significance of procalcitonin in patients with surgical forms of erysipelas.114 case histories of patients who were hospitalized in the center of purulent-septic surgery of the Non-profit municipal enterprise "City Hospital №3" in Zaporozhye for 2019-2020 period were analyzed retrospectively and prospectively. It was found that most often the focus was localized on the lower extremities. In the complex treatment of patients with erysipelas, the main place belongs to antibiotic therapy (ABT) and early surgical treatment of the area of the pathological process. Determination of the level of procalcitonin in the serum makes it possible to assess the progression and generalization of the process and is a sensitive test for the effectiveness of treatment.Radical surgery and timely targeted ABT are key elements of success in the treatment of surgical forms of erysipelas and are not subject to revision. Procalcitonin is a diagnostic marker that can predict the development of sepsis.http://journals.uran.ua/index.php/2307-0404/article/view/228011procalcitoninsurgical forms of erysipelas
spellingShingle S.D. Shapoval
L.A. Vasylevska
The use of procalcitonin in patients with surgical forms of erysipelas
Medičnì Perspektivi
procalcitonin
surgical forms of erysipelas
title The use of procalcitonin in patients with surgical forms of erysipelas
title_full The use of procalcitonin in patients with surgical forms of erysipelas
title_fullStr The use of procalcitonin in patients with surgical forms of erysipelas
title_full_unstemmed The use of procalcitonin in patients with surgical forms of erysipelas
title_short The use of procalcitonin in patients with surgical forms of erysipelas
title_sort use of procalcitonin in patients with surgical forms of erysipelas
topic procalcitonin
surgical forms of erysipelas
url http://journals.uran.ua/index.php/2307-0404/article/view/228011
work_keys_str_mv AT sdshapoval theuseofprocalcitonininpatientswithsurgicalformsoferysipelas
AT lavasylevska theuseofprocalcitonininpatientswithsurgicalformsoferysipelas
AT sdshapoval useofprocalcitonininpatientswithsurgicalformsoferysipelas
AT lavasylevska useofprocalcitonininpatientswithsurgicalformsoferysipelas